[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fortrea Holdings Inc (FTRE)

Fortrea Holdings Inc (FTRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,573,198
  • Shares Outstanding, K 94,600
  • Annual Sales, $ 2,723 M
  • Annual Income, $ -986,200 K
  • EBIT $ 32 M
  • EBITDA $ 907 M
  • 60-Month Beta 2.12
  • Price/Sales 0.57
  • Price/Cash Flow 1.66
  • Price/Book 2.96

Options Overview Details

View History
  • Implied Volatility 80.91% (-9.08%)
  • Historical Volatility 78.09%
  • IV Percentile 9%
  • IV Rank 9.17%
  • IV High 191.95% on 10/22/25
  • IV Low 69.69% on 01/21/26
  • Expected Move (DTE 1) 1.40 (8.78%)
  • Put/Call Vol Ratio 4.38
  • Today's Volume 70
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 3,913
  • Open Int (30-Day) 3,746
  • Expected Range 14.58 to 17.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.18
  • Number of Estimates 3
  • High Estimate $0.21
  • Low Estimate $0.14
  • Prior Year $0.19
  • Growth Rate Est. (year over year) -5.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.00 +22.92%
on 05/26/26
17.56 -8.98%
on 06/04/26
+2.32 (+16.98%)
since 05/15/26
3-Month
8.55 +86.90%
on 04/06/26
17.56 -8.98%
on 06/04/26
+6.71 (+72.38%)
since 03/16/26
52-Week
4.36 +266.93%
on 07/07/25
18.67 -14.41%
on 01/06/26
+10.19 (+175.99%)
since 06/16/25

Most Recent Stories

More News
3 Unpopular Stocks We’re Skeptical Of

3 Unpopular Stocks We’re Skeptical Of

BJRI : 51.78 (+0.33%)
FTRE : 15.98 (-3.91%)
EXPD : 164.02 (+0.48%)
1 Unprofitable Stock to Research Further and 2 We Question

1 Unprofitable Stock to Research Further and 2 We Question

FTRE : 15.98 (-3.91%)
BRZE : 21.18 (-2.53%)
MIDD : 165.02 (+0.92%)
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the granting of an inducement...

FTRE : 15.98 (-3.91%)
Fortrea to Attend Jefferies Global Healthcare Conference

DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that that CEO Anshul Thakral, CFO Jill McConnell,...

FTRE : 15.98 (-3.91%)
3 Overrated Stocks We Approach with Caution

3 Overrated Stocks We Approach with Caution

FTRE : 15.98 (-3.91%)
JELD : 1.8200 (+1.68%)
GNRC : 265.66 (-1.64%)
Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1

Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1

FTRE : 15.98 (-3.91%)
Fortrea’s Q1 Earnings Call: Our Top 5 Analyst Questions

Fortrea’s Q1 Earnings Call: Our Top 5 Analyst Questions

FTRE : 15.98 (-3.91%)
FTRE Q1 Deep Dive: Fortrea’s Commercial Momentum and Technology Focus Drive Margin Improvement

FTRE Q1 Deep Dive: Fortrea’s Commercial Momentum and Technology Focus Drive Margin Improvement

FTRE : 15.98 (-3.91%)
Fortrea (FTRE) Shares Skyrocket, What You Need To Know

Fortrea (FTRE) Shares Skyrocket, What You Need To Know

FTRE : 15.98 (-3.91%)
Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock Soars

Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock Soars

FTRE : 15.98 (-3.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based...

See More

Key Turning Points

3rd Resistance Point 17.27
2nd Resistance Point 16.98
1st Resistance Point 16.48
Last Price 15.98
1st Support Level 15.69
2nd Support Level 15.40
3rd Support Level 14.90

See More

52-Week High 18.67
Last Price 15.98
Fibonacci 61.8% 13.20
Fibonacci 50% 11.51
Fibonacci 38.2% 9.82
52-Week Low 4.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.